SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-23-000179
Filing Date
2023-11-08
Accepted
2023-11-08 20:32:53
Documents
1
Period of Report
2023-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1699493561.html 4  
1 FORM 4 wk-form4_1699493561.xml 4 7859
  Complete submission text file 0001694665-23-000179.txt   9256
Mailing Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
Bodmer Mark (Reporting) CIK: 0001738885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 231389721